相关实验视频
Updated: May 10, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.5K
梅特福林对糖尿病心脏手术患者痴呆症的影响
Zhongyuan Lu1,2, Mingyang Sun1, Wan-Ming Chen3,4
1Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Journal of anesthesia
|April 26, 2025
概括
在接受心血管手术的2型糖尿病患者中,甲福明显著降低了术后痴呆症 (POD) 的风险. 观察到剂量依赖的保护作用,突出显示其作为化学预防剂的潜力.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 老年病的医生 老年病的医生
- 药理学 药理学是指药理学的学科.
背景情况:
- 手术后妄 (POD) 是心血管手术患者的常见并发症.
- 患有2型糖尿病 (T2DM) 的患者患POD的风险增加.
- 在接受心血管手术的T2DM患者中减轻POD风险的甲福明的作用尚未得到充分证实.
研究的目的:
- 评估甲福明对T2DM心血管手术患者POD风险的影响.
- 分析来自台湾国家健康保险研究数据库的数据.
- 使用倾向得分匹配 (PSM) 来最大限度地减少混因素.
主要方法:
- 包括在2015年至2018年期间接受冠状动脉旁路移植 (CABG) 或门置换的T2DM患者.
- 应用PSM来平衡甲福林使用者与非使用者之间的共变量.
- 后勤回归和卡普兰-梅尔分析以评估POD风险和累积发病率.
主要成果:
- 甲胺使用与POD风险显著降低有关 (aOR,0.52;95%CI,0.40-0.67).
- 观察到一种剂量反应趋势,较高的累积甲福林暴露与较低的POD风险相关.
- 保护因素包括更高的收入,城市居住和他类药物的使用;风险因素包括年龄较大,长时间麻醉和更高的并发症得分.
结论:
- 在接受心血管手术的T2DM患者中,甲福明显著降低了POD的风险.
- 证明了甲福胺对POD的明显剂量依赖的保护作用.
- 在这种高风险人群中,甲胺显示出作为抗手术后并发症的化疗预防剂的潜力.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
125
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
125
Heart Failure Drugs: Inotropic Agents
405
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
405
Heart Failure Drugs: Diuretics
282
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
282
Diabetes: Management and Pharmacotherapy
207
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
207
Skeletal Muscle Relaxants: Adverse Effects
309
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
309

